Delayed peak serum valproic acid in massive divalproex overdose - Treatment with charcoal hemoperfusion

被引:34
作者
Graudins, A
Aaron, CK
机构
[1] Univ. of Massachusetts Med. Center, Worcester, MA
[2] Division of Toxicology, Department of Emergency Medicine, Univ. of Massachusetts Med. Center, Worcester, MA 01655
来源
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY | 1996年 / 34卷 / 03期
关键词
D O I
10.3109/15563659609013799
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Background: increased clearance and apparent clinical improvement in valproic acid overdose has been reported following in-series hemodialysis/hemoperfusion therapy. We report a case of divalproex sodium and chlorpheniramine overdose treated with charcoal hemoperfusion and multiple-dose activated charcoal. Case Report: A 32-year-old female presented alert three hours postingestion of her own medication. Serum valproic acid was 105 mu g/mL. No anticholinergic toxicity was seen. Despite three doses of activated charcoal over 14 hours, serum valproic acid continued to rise. Whole bowel irrigation and multiple-dose activated charcoal were commenced 17 h postingestion when serum valproic acid was 1380 mu g/mL. Charcoal hemoperfusion was instituted three hours later when serum valproic acid had not fallen and the patient remained obtunded. Results: Initial extraction ratio of the hemoperfusion cartridge was 0.54 with plasma clearance of 54.5 mL/min. Valproic acid elimination half-life was 3 h during the 190 min hemoperfusion cycle. Posthemoperfusion elimination half-life was 4.8 h with continued multiple-dose activated charcoal dosing. The clinical condition improved during hemoperfusion. Conclusion: Enteric coated valproic acid preparations may cause delayed toxicity in overdose, particularly with coingested anticholinergic medications. In our case, charcoal hemoperfusion appeared to increase valproic acid clearance.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 17 条
  • [1] LIFE-THREATENING INTOXICATION WITH SODIUM VALPROATE
    ANDERSEN, GO
    RITLAND, S
    [J]. JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1995, 33 (03): : 279 - 284
  • [2] CONCENTRATION-EFFECT RELATIONSHIPS OF VALPROIC ACID
    CHADWICK, DW
    [J]. CLINICAL PHARMACOKINETICS, 1985, 10 (02) : 155 - 163
  • [3] ACUTE VALPROIC ACID OVERDOSE - CLINICAL COURSE AND PHARMACOKINETIC DISPOSITION OF VALPROIC ACID AND METABOLITES
    DUPUIS, RE
    LICHTMAN, SN
    POLLACK, GM
    [J]. DRUG SAFETY, 1990, 5 (01) : 65 - 71
  • [4] ACUTE VALPROIC ACID INTOXICATION - ENHANCED DRUG CLEARANCE WITH ORAL-ACTIVATED CHARCOAL
    FARRAR, HC
    HEROLD, DA
    REED, MD
    [J]. CRITICAL CARE MEDICINE, 1993, 21 (02) : 299 - 301
  • [5] A CASE OF VALPROATE INTOXICATION WITH EXCESSIVE BRAIN EDEMA
    HINTZE, G
    KLEIN, HH
    PRANGE, H
    KREUZER, H
    [J]. KLINISCHE WOCHENSCHRIFT, 1987, 65 (09): : 424 - 427
  • [6] THE EFFECT OF HEMODIALYSIS AND HEMOPERFUSION ON SERUM VALPROIC ACID CONCENTRATION
    KANDROTAS, RJ
    LOVE, JM
    GAL, P
    OLES, KS
    [J]. NEUROLOGY, 1990, 40 (09) : 1456 - 1458
  • [7] KARLSEN RL, 1983, ACTA MED SCAND, V213, P405
  • [8] CEREBRAL EDEMA FOLLOWING ACUTE SODIUM VALPROATE OVERDOSE
    KHOO, SH
    LEYLAND, MJ
    [J]. JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1992, 30 (02): : 209 - 214
  • [9] KLOTZ U, 1977, CLIN PHARMACOL THER, V21, P736
  • [10] MORTENSEN PB, 1983, INT J CLIN PHARM TH, V21, P64